Founded in 1994 by Dr. Larry G. Horgen, Horgen Med is a full-service Contract Research Organization (CRO) based in Norway. With expertise across multiple therapeutic areas, we are especially dedicated to advancing the research and treatment of ALS.
Under the leadership of Dr. Horgen, a renowned clinical researcher, our team collaborates with global pharmaceutical companies, biotech firms, and research institutions to drive innovative clinical trials, drug development, and breakthrough therapies.
At Horgen Med, we are committed to accelerating medical progress, improving patient outcomes, and shaping the future of healthcare through scientific excellence and strategic partnerships.
At Horgen Med, our mission is to advance medical research and accelerate the development of life-changing treatments, with a strong focus on ALS and other critical therapeutic areas. Through scientific excellence, cutting-edge clinical trials, and strategic collaborations, we strive to bring innovative therapies to patients faster, improving healthcare outcomes worldwide.
Our vision is to be a global leader in clinical research, pioneering breakthroughs that transform the future of medicine. We aim to drive innovation, expand access to effective treatments, and contribute to a world where ALS and other debilitating diseases no longer pose an insurmountable challenge.